AAAAAA
Results: 1-25/28
Authors:
Emons, G
Citation: G. Emons, Hormone replacement treatment after menopause, DEUT MED WO, 126(9), 2001, pp. 253-254
Authors:
Fleckenstein, G
Heyl, W
Brinck, U
Pauer, U
Viereck, V
Emons, G
Citation: G. Fleckenstein et al., Surgical management of endosalpingiosis with tubovaginal fistulization after hysterectomy by a combined laparoscopic-vaginal route, and histological findings, GYNAEC ENDO, 10(2), 2001, pp. 131-136
Authors:
Meyer-Wittkopf, M
Barth, H
Emons, G
Schmidt, S
Citation: M. Meyer-wittkopf et al., Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature, ULTRASOUN O, 18(1), 2001, pp. 62-66
Authors:
Grundker, C
Schlotawa, L
Viereck, V
Emons, G
Citation: C. Grundker et al., Protein kinase C-independent stimulation of activator protein-1 and c-Jun N-terminal kinase activity in human endometrial cancer cells by the LHRH agonist triptorelin, EUR J ENDOC, 145(5), 2001, pp. 651-658
Authors:
Krauss, T
Nia, AH
Viereck, V
Emons, G
Citation: T. Krauss et al., New developments in the treatment of cervical cancer, ONKOLOGIE, 24(4), 2001, pp. 340-345
Authors:
Fleckenstein, G
Sattler, B
Hinney, B
Wuttke, W
Osmers, R
Emons, G
Citation: G. Fleckenstein et al., Androblastoma of the ovary: Clinical, diagnostic and histopathologic features, ONKOLOGIE, 24(3), 2001, pp. 286-291
Authors:
Grundker, C
Volker, P
Emons, G
Citation: C. Grundker et al., Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase, ENDOCRINOL, 142(6), 2001, pp. 2369-2380
Authors:
Emons, G
Fleckenstein, G
Hinney, B
Huschmand, A
Heyl, W
Citation: G. Emons et al., Hormonal interactions in endometrial cancer, ENDOCR-R CA, 7(4), 2000, pp. 227-242
Authors:
Hadji, P
Hars, O
Gorke, K
Emons, G
Schultz, KD
Citation: P. Hadji et al., Quantitative ultrasound of os calcis in postmenopausal women with spine and hip fractures, J CLIN DENS, 3(3), 2000, pp. 233-239
Authors:
Westphalen, S
Kotulla, G
Kaiser, F
Krauss, W
Werning, G
Elsasser, HP
Nagy, A
Schulz, KD
Grundker, C
Schally, AV
Emons, G
Citation: S. Westphalen et al., Receptor mediated antiproliferative effects of the cytotoxic LHRH agonist AN-152 in human ovarian and endometrial cancer cell lines, INT J ONCOL, 17(5), 2000, pp. 1063-1069
Authors:
Hadji, P
Hars, O
Bock, K
Sturm, G
Bauer, T
Emons, G
Schulz, KD
Citation: P. Hadji et al., The influence of menopause and body mass index on serum leptin concentrations, EUR J ENDOC, 143(1), 2000, pp. 55-60
Authors:
Emons, G
Weiss, S
Ortmann, O
Grundker, C
Schulz, KD
Citation: G. Emons et al., LHRH might act as a negative autocrine regulator of proliferation of humanovarian cancer, EUR J ENDOC, 142(6), 2000, pp. 665-670
Authors:
Hadji, P
Hars, O
Sturm, G
Bauer, T
Emons, G
Schulz, KD
Citation: P. Hadji et al., The effect of long-term, non-suppressive levothyroxine treatment on quantitative ultrasonometry of bone in women, EUR J ENDOC, 142(5), 2000, pp. 445-450
Authors:
Hadji, P
Gorke, K
Hars, O
Bauer, T
Emons, G
Schulz, KD
Citation: P. Hadji et al., The influence of hormone replacement therapy (HRT) on serum leptin concentration in postmenopausal women, MATURITAS, 37(2), 2000, pp. 105-111
Authors:
Emons, G
Heyl, W
Citation: G. Emons et W. Heyl, Hormonal treatment of endometrial cancer, J CANC RES, 126(11), 2000, pp. 619-623
Authors:
Grundker, C
Volker, P
Schulz, KD
Emons, G
Citation: C. Grundker et al., Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers, GYNECOL ONC, 78(2), 2000, pp. 194-202
Authors:
Emons, G
Schulz, KD
Citation: G. Emons et Kd. Schulz, Primary and salvage therapy with LH-RH analogues in ovarian cancer, REC RES CAN, 153, 2000, pp. 83-94
Authors:
Grundker, C
Schulz, K
Gunthert, AR
Emons, G
Citation: C. Grundker et al., Luteinizing hormone-releasing hormone induces nuclear factor kappa B-activation and inhibits apoptosis in ovarian cancer cells, J CLIN END, 85(10), 2000, pp. 3815-3820
Assessment by quantitative ultrasonometry of the effects of hormone replacement therapy on bone mass
Authors:
Hadji, P
Hars, O
Schuler, M
Bock, K
Wuster, C
Emons, G
Schulz, KD
Citation: P. Hadji et al., Assessment by quantitative ultrasonometry of the effects of hormone replacement therapy on bone mass, AM J OBST G, 182(3), 2000, pp. 529-534
Authors:
Ballauff, A
Ziegler, A
Emons, G
Sturm, G
Blum, WF
Remschmidt, H
Hebebrand, J
Citation: A. Ballauff et al., Serum leptin and gonadotropin levels in patients with anorexia nervosa during weight gain, MOL PSYCHI, 4(1), 1999, pp. 71-75
Authors:
Emons, G
Kavanagh, JJ
Citation: G. Emons et Jj. Kavanagh, Hormonal interactions in ovarian cancer, HEMAT ONCOL, 13(1), 1999, pp. 145
Authors:
Ortmann, O
Asmus, W
Diedrich, K
Schulz, KD
Emons, G
Citation: O. Ortmann et al., Interactions of ovarian steroids with pituitary adenylate cyclase-activating polypeptide and GnRH in anterior pituitary cells, EUR J ENDOC, 140(3), 1999, pp. 207-214
Authors:
Hadji, P
Hars, O
Wuster, C
Bock, K
Alberts, US
Bohnet, HG
Emons, G
Schulz, KD
Citation: P. Hadji et al., Stiffness index identifies patients with osteoporotic fractures better than ultrasound velocity or attenuation alone, MATURITAS, 31(3), 1999, pp. 221-226
Authors:
Gunthert, AR
Pilz, S
Kuhn, W
Emons, G
Meden, H
Citation: Ar. Gunthert et al., Docetaxel is effective in the treatment of metastatic endometrial cancer, ANTICANC R, 19(4C), 1999, pp. 3459-3461
Authors:
Hadji, P
Hars, O
Bock, K
Albert, US
Beckmann, MW
Emons, G
Schulz, KD
Citation: P. Hadji et al., Age changes of calcaneal ultrasonometry in healthy German women, CALCIF TIS, 65(2), 1999, pp. 117-120